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Abstract
Background: Measles is a highly contagious and potentially fatal illness preventable through vaccination. Outbreaks in the
UK and many other European countries have been increasing over recent years, with over 3,207 laboratory-confirmed cases
reported by Public Health England from January 2012 to the end of June 2013. To aid rational decision making regarding
measles control versus other use of healthcare resources, it is important to measure the severity of measles in units that are
comparable to other diseases. The standard metric for this in the UK is the quality-adjust life year (QALY). To our knowledge,
the impact of measles on health-related quality of life (HRQoL) in terms of QALYs has not been quantified.
Methods and Findings: Individuals with confirmed measles were sent questionnaires requesting information on the short-
term impact of the illness on their HRQoL using the EuroQol EQ-5D-3L questionnaire. HRQoL was reported for the day the
questionnaire was received, the worst day of infection and at follow-up three weeks later. 507 questionnaires were sent to
individuals with confirmed measles with 203 returned (40%). The majority of respondents were not vaccinated. The mean
time off work or school was 9.6 days. The mean duration of perceived illness was 13.8 days. The mean number of QALYs lost
was 0.019 (equivalent to 6.9 days). The overall burden of disease in terms of QALYs lost in England based on the total
number of confirmed cases in the twelve month period from 1st June 2012 was estimated to be 44.2 QALYs.
Conclusion: The short-term impact of measles infection on HRQoL is substantial, both at the level of the individual patient
and in terms of the overall disease burden. This is the first attempt to quantify QALY-loss due to measles at a population
level, and provides important parameters to guide future intervention and control measures.
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Introduction
Measles is a highly infectious notifiable disease that can be
severe in infants, pregnant women and immunocompromised
individuals [1,2]. Measles is preventable through the measles-
mumps-rubella vaccination programme (MMR), with measles
vaccination introduced in the UK in 1968 [1]. The reported
coverage is 92.9% [3] although uptake fell in the late 1990s from
92% in 1996 to 80% in 2003 [4] after the suggestion of a potential
link between the vaccine and autism [5] that subsequently proved
to be unfounded [6–8].
Previous measles outbreak reports focus on the epidemiology of
the disease [9–11], rather than the overall disease burden in terms
of health-related quality of life (HRQoL). The impact of infectious
diseases on HRQoL is a developing field of research, whose aim is
to express the burden of disease not only in number of cases but
also in disease days and the impact of these disease days. Doing so
enables a comparison between diseases and helps in the fair
allocation of resources. In England the evaluation of resource
allocation is formalised in cost-effectiveness analyses [12,13].
A standard method to measure the disease burden is the use of
quality-adjusted life years (QALYs). A QALY is a generic measure
incorporating both the length of time that patients experience
health reduction and the magnitude of the health reduction [14].
To calculate QALYs first the condition-specific health utilities,
which give an estimate of the impact on HRQoL for the condition
in question, must be established. Health utilities commonly take
values between 0 and 1, corresponding to utilities for death and
perfect health respectively (although some systems of measurement
allow utilities of less than 0 to be reported). These utilities are used
in conjunction with the duration of the health reduction to
calculate the QALY-loss (and thus the potential QALY-gain for
any proposed intervention or new health technology).
To our knowledge, no measure of health utilities has previously
been attempted for measles, despite the global significance of this
infection. This study attempts to gather health utilities specific to
measles during the 2012-13 regional measles epidemics in
England, as well as other direct and indirect effects of a measles
epidemic on a population including symptoms during infection;
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disruption at home due to time off work or school for individuals
with confirmed measles; hospitalisations and carer time off work.
Methods
In this study, standardised postal questionnaires were sent to
individuals with confirmed or suspected measles. Questionnaires
were sent to individuals with suspected measles in the North West
England outbreak from 1st June 2012 and the study was extended
throughout England from 2nd October 2012 to 5th July 2013
targeting only individuals with confirmed measles.
Case definition
Individuals with suspected measles were confirmed positive if
they were measles immunoglobulin M-positive on saliva or
through polymerase chain reaction testing in urine, saliva or a
throat swab. A suspected measles case was defined using the
following criteria from Vivancos et al. 2012 [11]:
N Clinical presentation: fever and measles-like rash and one or
more of the following symptoms: cough, conjunctivitis, coryza,
or Koplik’s spots.
N Residence/reported from: residence or history of travel to
endemic, outbreak or adjacent areas, or being a close contact
of a confirmed or probable case of measles.
Exclusion criteria
Individuals in traveller communities with laboratory-confirmed
measles were not invited to participate in the study, because Public
Health England engages with this community through different
protocols and procedures [15]. A member of the traveller
community was defined as someone self-identifying as a member
of the traveller community or someone living on a traveller site,
whether authorised or not authorised.
We excluded individuals with confirmed measles with a
reported symptom onset date more than two weeks before case
status was confirmed to minimise the time between perceived
symptom onset and receiving the first questionnaire.
Unless stated, the analysis that follows is based on individuals
with confirmed measles.
EuroQol EQ-5D-3L
The EuroQol EQ-5D-3L is a generic multi-attribute health-
state classification system [16,17]. HRQoL is assessed in five
dimensions: mobility, self-care, usual activities, pain/discomfort
and anxiety/depression. Each dimension is assessed using three
levels: no problems, some problems and severe problems,
facilitating the evaluation of 243 ( = 35) different health states.
The EuroQol scoring algorithm converts the responses into a
health utility specific to the individual’s health state. A visual
analogue scale (VAS) invites the individual to rate their health
state on a scale from 0 – 100, with 0 being the worst health state
imaginable and 100 being the best health state imaginable. The
National Institute for Health and Clinical Excellence recommends
the EuroQol EQ-5D-3L for use in cost-effectiveness analyses in
the United Kingdom [13].
Three age-specific EQ-5D-3L questionnaires were used: the
standard EQ-5D-3L for all individuals aged 13 years and older;
the child-friendly EQ-5D-Y for all individuals aged between 7 – 12
years [18] and a proxy version of the standard EQ-5D-3L for
individuals aged less than 7 years to be completed by the child’s
parent or guardian. All three versions of the questionnaire use
both the same algorithm and scoring tariff to convert responses
into health utilities.
One year is equivalent to 365 days; therefore 1 QALY would be
equivalent to 365 quality-adjusted life days (QALDs). The QALD
has previously been used to report the impact of influenza on
HRQoL [19], and for ease of interpretation we express loss of
HRQoL in terms of QALDs below.
Questionnaires
Individuals were sent an initial questionnaire requesting details
of their illness and its impact on their HRQoL for both the worst
day of infection and the day that the questionnaire was received
using the EQ-5D-3L. Three weeks later they were sent a follow-up
questionnaire to obtain a further HRQoL measurement at
recovery. Individuals who did not return the first questionnaire
were sent it a second time along with the follow-up questionnaire
three weeks later. We assumed that a three week period was
sufficient for typical symptoms of measles to subside [20], and we
assumed that if individuals reported that they had recovered then
they were no longer suffering a measles-related reduction in their
HRQoL. The value of HRQoL reported by individuals who
reported having recovered was treated as their baseline HRQoL
for the purposes of calculating QALY loss.
To assess the impact of measles infection on HRQoL, patients
must complete the EQ-5D-3L when healthy (at recovery) and for
the worst day of infection. We assumed that the QALY loss
associated with measles for each individual can be represented by
a triangular shape, as shown in Figure 1. A more precise picture
would be possible if patients completed the EQ-5D-3L more
frequently during their infection. In absence of these data we
assume that we can represent the QALY loss as a linear
deterioration in HRQoL from a recovery reading to its level on
the worst day of infection. As a comparison, we also estimated
HRQoL directly using the VAS, with HRQoL given by VAS
score divided by 100.
Notification of potential study participants was received by the
specialist epidemiologist for measles at Public Health England in
Colindale who excluded ineligible patients. Letters and question-
naires were sent using a database updated daily with new
notifications of suspected measles cases. In the analysis that
follows, we consider only those individuals with laboratory-
confirmed measles.
Anonymised data
All questionnaires sent to confirmed or suspected measles cases
were anonymised. A questionnaire was linked to the appropriate
follow-up questionnaire using the HP Zone ID, an anonymised ID
data field used on Public Health England databases. Sensitive
patient identifiers such as the distribution address were handled by
Public Health England, whereas the returned and anonymous
questionnaires were processed by researchers at the London
School of Hygiene and Tropical Medicine, with no links or access
to the original sensitive information. All medical records used in
the analysis were also anonymised by Public Health England using
the HP Zone ID.
Ethics approval
In accordance with The Health Service (Control of Patient
Information) Regulations 2002 No. 1438 Section 251 Regulation
3 [21], Public Health England may process confidential patient
information with a view to monitoring and managing
i. outbreaks of communicable disease;
ii. incidents of exposure to communicable disease;
Measles and Health-Related Quality of Life
PLOS ONE | www.plosone.org 2 September 2014 | Volume 9 | Issue 9 | e105153
iii. the delivery, efficacy and safety of immunisation pro-
grammes.
Data analysis
Data were analysed using Microsoft Excel 2007 and R (version
3.0.2) [22]. Public Health England obtained hospitalisation
records for individuals who received the questionnaire, so
hospitalisation rates were compared between responders and
non-responders to test for severity bias. HRQoL data were
analysed only for those patients who completed all five dimensions
of health on the EQ-5D-3L in addition to reporting the duration
of their illness. We calculated the QALY-loss due to measles using
the EQ-5D-3L and the VAS and compared the two systems. We
examined the three age-specific EQ-5D-3L questionnaires and
looked for differences in the QALYs lost due to measles infection.
Reported 95% confidence intervals of the means are based on
1,000 bootstrap replications.
The EQ-5D-3L requires the respondent to complete all five
dimensions of the classification system in order to calculate a
health-state utility. Omitting the response to any of the dimensions
means the remaining responses cannot be used for this purpose,
therefore a missing-value regression analysis was conducted using
the VAS score to estimate the EQ-5D-3L utility where patients
had completed the VAS but not all five dimensions of health.
When assessing the HRQoL in individuals with haemophilia
Miners et al. [23] showed a correlation between EQ-5D-3L utility
and the VAS scores (R= 0.67, p,0.0001).
Results
683 questionnaires were sent; 507 to individuals with confirmed
measles and 176 to individuals with unconfirmed/suspected
measles. 203 questionnaires were returned from those with
confirmed measles (40.0%). 45 questionnaires from individuals
with unconfirmed/suspected measles were returned (25.6%). From
the 203 individuals with confirmed measles who returned their
first questionnaires we received 63 follow-up questionnaires
(31.0%). 103 of the returned first questionnaires had been
completed after recovery from measles so the HRQoL measure-
ment on the day of completion could be used as the recovery
HRQoL measurement.
Demographic and vaccination data
101 (49.8%) of the 203 responses were from female patients. 68
(33.5%) of the respondents were under five years old (Figure 2).
188 (92.6%) had not yet received their first dose of the MMR
vaccine. The age distribution of those individuals who returned the
questionnaire was similar to the age distribution of confirmed
measles cases invited to participate (Figure 2).
Severity bias
Among the 507 individuals with confirmed measles to whom
questionnaires were sent, Public Health England could not obtain
hospitalisation records for 20 individuals (3.9%) as their GP’s
database had not been updated with any details of potential
hospitalisations post-notification. Of the remaining individuals, 75
of the 199 individuals who were hospitalised returned their
questionnaire and 120 of the 288 individuals not hospitalised
Figure 1. Illustration of the calculation of short-term loss of health-related quality of life (HRQoL). HRQoL is plotted against time; the
area of the black triangle represents the loss of HRQoL due to illness.
doi:10.1371/journal.pone.0105153.g001
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returned theirs. We found that there was no evidence that
hospitalised individuals were more likely to return the question-
naires (x2 = 0.78 and p= 0.38).
The remaining results refer only to the 203 questionnaires
returned by individuals with confirmed measles. Figure 3 shows
the number of questionnaires sent and eventually used in the
analysis.
Impact at home
128 (63.1%) individuals with confirmed measles reported
spending time off work or school due to measles infection
(Table 1), of whom those who had fully recovered reported a
mean time spent at home of 9.6 days (95% CI: 9.3 – 11.7). 75
(36.9%) individuals with confirmed measles reported that a
caregiver spent time away from work during their infection, of
whom those who had fully recovered reported a mean time spent
away from work by carers of 7.3 days (95% CI: 5.7 – 7.9). 74
(36.5%) individuals reported spending at least one night in
hospital, of whom those who had fully recovered reported a mean
length of stay of 4.2 nights (median 4.0 nights). The median worst
day of perceived symptoms was the fifth day and the mean
duration of perceived symptoms was 13.8 days (95% CI: 12.6 –
15.1).
Contact with the health services
193 (95.1%) individuals with confirmed measles reported at
least one contact with the health services. The remaining 10
individuals may have come to the attention of the local Health
Protection Unit (HPU) through contact tracing of another
confirmed measles case or may have been reported directly to
the HPU by a teacher, parent or guardian, thereby not having any
contact with the health services before their case status was
confirmed. The median number of contacts with the health
services was 3.0 during the period of infection but this was highly
skewed with a mean of 4.0 and 5 people having more than 10
contacts. The mean time between perceived symptom onset and
first contacting the different local health services was about 3.6
days irrespective of which service (NHS Direct, GP, A&E, etc.) was
first contacted.
EQ-5D-3L dimensions results
91 of the 203 confirmed measles cases completed all five
dimensions of health for the EQ-5D-3L on the worst day of
infection and after a full recovery from measles infection and
reported the duration of perceived symptoms, thus enabling the
calculation of QALYs lost. On the worst day of infection, these
individuals reported their health according to each of the EQ-5D-
3L dimensions of health as shown in Table 2.
Figure 2. Age-specific distribution of questionnaires sent, questionnaire response, and vaccination status for confirmed cases of
measles. The right columns of each age group show the age-distribution of questionnaires sent to confirmed measles cases (left axis); the left
columns show the age-distribution of responses (left axis), split into those who are have received no MMR vaccinations (black), one MMR vaccination
(diagonal stripe) and two MMR vaccinations (horizontal stripe).
doi:10.1371/journal.pone.0105153.g002
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Figure 3. Flow chart for the study showing the number of questionnaires that were distributed to confirmed measles cases; the
number of questionnaires returned for analysis; and the number of questionnaires returned for analysis that included the
necessary information for EQ-5D-3L health utilities to be calculated.
doi:10.1371/journal.pone.0105153.g003
Measles and Health-Related Quality of Life
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194 of the 203 individuals with confirmed measles (95.6%) who
returned a questionnaire also returned a completed VAS.
HRQoL results
The overall QALY loss, calculated using the EuroQol EQ-5D-
3L, associated with measles was 0.019 QALYs per patient (95%
CI: 0.016 – 0.022), the equivalent of 6.9 QALDs per patient (95%
CI: 5.84 – 8.02) (Table 3).
HRQoL through the VAS
The overall QALY loss associated with measles using the VAS
score was the equivalent of 4.92 QALDs (95% CI: 4.15 – 5.86) or
0.013 QALYs (95% CI: 0.011 – 0.016). There is very strong
evidence that the VAS gives different results when compared to
the EQ-5D-3L algorithm using the paired Wilcoxon test (V= 649,
p,0.0001) using the HRQoL results from the 91 individuals with
confirmed measles who completed all aspects of the EuroQol EQ-
5D questionnaire.
Overall burden of regional epidemics
Public Health England reported that there had been 2,366
laboratory-confirmed cases of measles in England for twelve
months from 1st June 2012, the beginning of the study period
[24,25]. Using our estimates above for the burden of measles
infection, the age-adjusted overall burden of disease in this period
was approximately 16,164 QALDs (95% CI: 15,740 – 16,645), or
44.2 QALYs (95% CI: 43.2 – 45.6). 1,534 of these confirmed cases
would have taken time off work or school, resulting in 14,527 age-
adjusted days of lost productivity (95%CI: 14,215 – 14,848). When
including primary caregivers taking time off work, a further 904
people would have taken time off work resulting in an age-adjusted
total number of 23,110 days of lost productivity (95%CI: 22,661 –
23,522). 95% confidence intervals of the mean are based on 1,000
bootstrap replications.
Missing data analysis
Each patient was sent a maximum of three EQ-5D-3L
questionnaires: for the worst day of infection, for the date that
the first questionnaire was received and the recovery HRQoL
reading. From a maximum of 744 eligible questionnaires from
both individuals with confirmed measles and individuals with
unconfirmed/suspected measles, 397 contained both a EQ-5D-3L
questionnaire with responses to all dimension of HRQoL and a
completed VAS score.
Assuming that EQ-5D responses were missing at random and
that the VAS score can be used to predict missing EQ-5D utilities,
we used a multiple imputation method through the Amelia II
statistical package in R [26] to impute EQ-5D utilities where the
individual had completed the VAS. This added 26 more
observations and the overall QALY loss from the interpolated
data was equivalent to 6.81 days (95% CI 5.68 – 8.04), very similar
to the QALY and equivalent QALD loss from non-interpolated
data reported in Table 3.
Table 1. Impact of measles infection.
Among confirmed
measles cases (n=203)
Age under
7 years (n =70)
Age 7–12
years (n=25)
Age 13 years and
over (n =108)
Worst day (median, mean, mode) 5, 5.61, 4 5, 5.58, 5 6, 7.56, 5 5, 5.15, 4
Mean duration of perceived symptoms (95% CI) 13.8 days (12.6 – 15.1) 12.8 days (11.0 – 14.9) 13.5 (10.4 – 17.1) 14.4 (12.7 – 16.2)
Individuals reporting time off work or school 128 (63.1%) 26 (37.1%) 22 (88.0%) 80 (74.1%)
Mean time off work or school for patients (95% CI) 9.6 days (9.3 – 11.7) 8.6 days (6.8 – 10.5) 9.1 days (7.4 – 10.8) 10.1 days (8.8 – 11.5)
Individuals reporting time off work for primary caregivers 75 (39.6%) 31 (44.3%) 10 (40.0%) 34 (31.5%)
Mean time off work for primary caregivers (95% CI) 7.3 days (5.7 – 7.9) 7.0 days (4.9 – 9.2) 7.7 days (4.3 – 11.3) 7.2 days (5.0 – 9.5)
Individuals reporting at least one night in hospital 74 (36.5%) 23 (32.9%) 2 (8.0%) 49 (45.4%)
Number of nights spent in hospital (median, mean, mode) 4.0, 4.2, 1.0 3.0, 4.0, 1.0 4.0, 4.0, 4.0 4.0, 4.4, 1.0
The mean time off work or school for patients and for primary caregivers is the mean time for those who reported at least one day of absence. Likewise, the number of
nights in hospital applies only to those individuals who reported at least one night in hospital. 95% confidence intervals of the mean are based on 1,000 bootstrap
replications. The first column shows results for the whole sample; the subsequent 3 columns split the sample into the three age groups considered.
doi:10.1371/journal.pone.0105153.t001
Table 2. Responses to each dimension of health for the worst day of infection for individuals with confirmed measles who
provided the full data set to facilitate the calculation of QALY loss associated with measles.
Evaluating HRQoL on the worst day of infection (n=91)
EQ-5D dimensions of health No problems Some problems Severe problems
Mobility 10 (11.0%) 35 (38.5%) 46 (50.5%)
Self-care 20 (22.0%) 35 (38.5%) 36 (39.6%)
Usual activities 3 (3.3%) 17 (18.7%) 71 (78.0%)
Pain or discomfort 9 (9.9%) 45 (49.5%) 37 (40.7%)
Anxiety or depression 33 (36.3%) 34 (37.4%) 24 (26.4%)
doi:10.1371/journal.pone.0105153.t002
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Implications for missing HRQoL data
49 (70%) of the 70 EQ-5D proxy questionnaires for children
aged under 7 years for the worst day of infection returned were
missing in the self-care dimension (Table 4). This suggests that
parents or guardians have difficultly completing this dimension of
the EQ-5D-3L as a proxy for their young children. 28 of the
returned EQ-5D proxy questionnaires (40%) did not have a
response recorded in the mobility dimension. Fewer missing
responses were returned for the remaining three dimensions.
None of the 25 EQ-5D-Y questionnaires for children aged 7 –
12 years had a missing response for any of the five dimensions on
the worst day of infection. Few EQ-5D-3L questionnaires for
individuals aged 13 years and older had missing responses for the
dimensions of health: 5 questionnaires (4.6%) were missing a
response in the mobility dimension, with fewer missing responses
in the remaining dimensions.
Measuring HRQoL using age-specific EQ-5D-3L
The standard EQ-5D-3L was used by individuals aged 13 years
and older. The mean QALD-loss attributable to measles for this
group was 6.9 days (95% CI: 4.9 – 9.1). For individuals aged
between 7 – 12 years the EQ-5D-Y was used to report a mean
QALD-loss of 7.3 days (95% CI: 3.7 – 13.0). For infants aged
under 7 years the EQ-5D (proxy) was used to report a mean
QALD-loss of 6.2 days (95% CI: 3.6 – 9.0). Using the independent
Mann-Whitney test there was no evidence that the measured
HRQoL loss is dependent on the EQ-5D-3L questionnaire used
(W=483.5 and p= 0.64 when compared to EQ-5D-Y; W=433.5
and p= 0.99 when compared to EQ-5D proxy).
Discussion
We have used the confirmed measles cases reported since June
2012 to calculate the short-term impact on HRQoL of measles,
with measurements taken during the 2012-13 regional measles
epidemics in England. We found that measles infection causes a
short-term QALY-loss of 0.019 QALYs, or 6.9 QALDs, per
patient, with perceived symptoms lasting 13.8 days. For context,
the short-term impact on HRQoL of H1N1v influenza was 0.008
QALYs, or 2.92 QALDs, per patient [19]. The impact on
HRQoL of natural varicella was 0.0027 QALYs, or 0.99 QALDs
(,15 years old) [27] and 0.0038 QALYs, or 1.39 QALDs ($15
years old) per patient [28].
To our knowledge this is the first attempt to calculate the impact
on HRQoL of measles infection. This study was a patient-based
retrospective study that invited all eligible confirmed cases of
measles since mid-2012 in the general population to participate.
The response rate was reasonable for a postal survey with a return
rate of 40%. In addition to quantifying the short-term impact of
measles on HRQoL we have also described the wider impact in
terms of time off work or school for individuals with measles and
their primary caregivers.
With MMR coverage still below the herd immunity threshold,
the potential for further measles outbreaks still exists within
England. Following this study, cost-effectiveness analyses for
possible interventions for such outbreaks may now be performed
using QALYs, so that a single generic metric is compared across all
analyses.
Using the VAS to derive health QALDs underestimates the
impact of measles infection on HRQoL in comparison to the EQ-
5D-3L, according to our sample of individuals with confirmed
measles. Indeed, the VAS is not a preference-based system so it
should not be used alone to calculate QALYs [29].
55.2% of individuals with confirmed measles who returned their
questionnaires did not provide all of the data necessary to calculate
QALY loss associated with measles infection. Completion was
poor for the EQ-5D proxy version administered to parents or
guardians to complete on behalf of a child aged less than 7 years;
70% of returned EQ-5D proxy questionnaires had a missing
response to the self-care dimension (Table 4). This is hardly
surprising, since it is unclear how one ought to answer such a
question, but it means that the proxy form of the EQ-5D-3L may
not be appropriate for evaluating a young child’s HRQoL. Fewer
completion issues were evident with the EQ-5D-3L for individuals
with confirmed measles aged 13 and older, and no completed
issues were evident for the EQ-5D-Y administered to children
aged 7 – 12 years. In contrast to the missing responses to the
questions about health dimensions, 95.6% of individuals with
confirmed measles who returned a questionnaire also returned a
completed VAS; this suggests that individuals with confirmed
measles found it easier to complete the VAS than the EQ-5D-3L
dimensions.
We found that estimated HRQoL loss is not dependent on the
EQ-5D-3L questionnaire used, i.e. the EQ-5D proxy and EQ-5D-
Y give similar values of HRQoL when compared to the standard
EQ-5D-3L. However, we note that both the EQ-5D-Y and EQ-
5D proxy questionnaires currently use the same scoring tariff as
the EQ-5D-3L. That is, the value of different health states
measured by the EQ-5D-3L is assumed to be identical for all
respondents in our study. This assumption has been challenged in
the past [30-32] and EuroQol are currently developing a child-
specific tariff for the EQ-5D-Y.
Table 3. Impact on HRQoL of measles for the 91 individuals with confirmed measles for whom QALY loss could be calculated
using the EQ-5D-3L.
Health-related quality
of life results (n =91)
Age under 7 years
(n =15)
Age 7–12 years
(n=18)
Age 13 years and over
(n =58)
EQ-5D Baseline HRQoL (95% CI) 0.96 (0.93 – 0.98) 0.89 (0.78 – 0.98) 0.98 (0.96 – 1.00) 0.94 (0.91 – 0.97)
EQ-5D Worst day HRQoL (95% CI) 0.00 (20.09 – 0.09) 20.26 (20.43 – 20.08) 20.07 (20.22 – 0.10) 20.05 (20.13 – 0.04)
VAS Background (95% CI) 92 (90 – 94) 93 (91 – 95) 91 (87 – 95) 89 (86 – 91)
VAS Worst day (95% CI) 21 (17 – 24) 18 (14 – 22) 19 (13 – 25) 19 (15 – 23)
Overall QALY loss (95% CI) 0.019 (0.016 – 0.022) 0.017 (0.012 – 0.022) 0.020 (0.014 – 0.028) 0.019 (0.016 – 0.023)
Overall QALD loss (95% CI) 6.90 (5.84 – 8.02) 6.29 (4.51 – 8.11) 7.28 (5.07 – 10.10) 6.94 (5.73 – 8.33)
95% confidence intervals of the mean are based on 1,000 bootstrap replications. The first column shows results for the whole sample; the subsequent 3 columns split
the sample into the three age groups considered.
doi:10.1371/journal.pone.0105153.t003
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We note that in the regional epidemics in Cheshire and
Merseyside only 18% of confirmed cases were hospitalised [11], in
comparison to 36.5% of our sample reporting spending at least
one night in hospital, though the authors of that study suggested
that the hospitalisation data from that study may underestimate
the true rate. From our sample of confirmed cases we did not find
evidence that the more severe cases were more likely to respond to
our questionnaire.
Limitations
This study was a retrospective evaluation of the impact of
measles infection on short-term HRQoL, using self-reported
metrics. It would be preferable to evaluate short-term HRQoL
loss in a controlled environment with daily EQ-5D-3L question-
naire completion and additional laboratory confirmation of items
such as onset date and duration of infection. However, our study
protocol followed similar evaluations of HRQoL loss for other
infectious disease and was successfully designed and executed
during a nationwide measles outbreak.
We assumed that the deterioration in HRQoL is linearly related
to the duration of infection (Figure 1) and used a triangular shape
to describe the QALY loss. This assumption could be tested if
HRQoL were measured more often over the course of measles
infection, providing sufficient information to gauge how HRQoL
varies during infection. However, this proposal may be infeasible
as it places a larger burden on the individuals with measles during
their period of infection. When Hollmann et al. (2013) [33]
calculated the impact of H1N1 influenza on patients in Spain they
assumed that the health utility corresponding to the worst day of
infection is experienced constantly throughout infection. This
assumption means that HRQoL drops to its lowest possible level
from day one of infection and returns to its highest level upon
recovery. In comparison to our method, this doubles the impact on
HRQoL.
Individuals were unlikely to complete the EQ-5D-3L for the
worst day of their illness on that day, as we were unable to send
questionnaires to individuals until after confirmation of measles
was received, which was likely to be after the worst day of illness.
This may be a source of recall bias but we attempted to minimise
this by sending questionnaires to confirmed cases as quickly as
possible. The median time between the perceived symptoms onset
and the date of completing the questionnaire was 12.0 days (mean
16.8 days, mode 5.0 days). Using the independent Wilcoxon test
we found no evidence that the short-term impact on HRQoL was
associated with the length of time between perceived symptoms
onset and the date of completion of the questionnaire. Those
individuals completing the questionnaire within one week of
perceived symptoms onset reported a mean QALD-loss of 7.88
days (95% CI: 5.1 – 11.92), as compared to those completing the
questionnaire between 8 – 14 days (5.64 QALDs, 95% CI: 3.03 –
8.16, W=200 and p= 0.29) and to those completing the
questionnaire more than 14 days after symptom onset (6.03
QALDs, 95% CI: 4.30 – 8.12, W=543 and p= 0.19).
10 patients reported that they did not have any contact with the
health services before their case status was confirmed. This may be
because they were already known to the local HPU through
contact tracing of another confirmed case or were separately
reported to the HPU without contacting the health services.
However, we recognise that they may have failed to report a
contact with the health services before notification to the HPU and
therefore could be a source of misclassification bias in our study.
In our calculation of QALY loss due to measles we used the
reported perceived length of symptoms rather than duration of
illness as obtained through serology. However, we feel that this
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assumption and use of a proxy is justified as an individual will only
report a lower health state to their preferred health state when
their symptoms affect their wellbeing; thus perceived symptoms
are the relevant factor.
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